JW Pharmaceutical Corporation (KRX:001060)

JW Pharmaceutical Revenue

JW Pharmaceutical had revenue of 222.02B KRW in the quarter ending June 30, 2026, with 16.18% growth. This brings the company's revenue in the last twelve months to 820.86B, up 10.50% year-over-year. In the year 2025, JW Pharmaceutical had annual revenue of 775.30B with 7.77% growth.

• Revenue (ttm): 820.86B
• Revenue Growth: +10.50%
• P/S Ratio: 0.77
• Revenue / Employee: 782.52M
• Employees: 1,049
• Market Cap: 634.30B

Revenue Chart

Chart

Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	775.30B	55.92B	7.77%
Dec 31, 2024	719.38B	-29.15B	-3.89%
Dec 31, 2023	748.53B	64.18B	9.38%
Dec 31, 2022	684.35B	77.77B	12.82%
Dec 31, 2021	606.58B	59.25B	10.83%

Data Source: S&P Global Market Intelligence Last updated: Aug 14, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Sep 18, 2026

Data Sources Report a data error